查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2086227

病人參與解決方案市場：按組件、交付管道、治療領域、定價模式、部署模式、應用和最終用戶分類－2026-2032年全球市場預測

Patient Engagement Solution Market by Component, Delivery Channel, Therapy Area, Pricing Model, Deployment Mode, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，病人參與解決方案市場將成長至 800.2 億美元，複合年成長率為 16.79%。

主要市場統計數據
基準年 2025 269.9億美元
預計年份：2026年 312.9億美元
預測年份 2032 800.2億美元
複合年成長率 (%) 16.79%

病人參與解決方案已成為現代醫療服務體系的核心組成部分，它透過數位化入口、病患入口網站、安全通訊、遠端患者監護監測、預約管理、用藥依從性支援工具和個人化教育等方式，將病患、臨床醫生、保險公司和照護團隊連接起來。隨著醫療系統面臨持續的壓力，需要在提高醫療服務可及性、改善治療效果、提升患者滿意度和保障醫療連續性的同時，應對人員短缺、慢性病負擔加重以及混合型醫療服務需求不斷成長等問題，患者參與解決方案的重要性日益凸顯。

檢驗的政策和醫療保健趨勢支持這一轉變。世界衛生組織（世衛組織）的《全球數位健康戰略》、美國國家醫療資訊科技協調辦公室（ONC）的《互通性議程》、美國醫療保險和醫療補助服務中心（CMS）的基於價值的醫療保健計劃以及歐洲的「歐洲健康數據空間」舉措，都在朝著更加協作、以患者為中心的數位健康生態系統邁進。對於醫療保健領導者而言，病人參與技術不再是無關緊要的體驗，而是提升醫療品質、減少不必要的醫療資源使用、支持協作決策以及推動數據驅動型醫療路徑的關鍵營運能力。

病人參與領域的變革性變化

病人參與解決方案的格局正受到消費者期望、互通性、混合醫療模式和績效付費機制的重塑。患者越來越期望獲得與其他數位服務類似的醫療保健體驗，包括行動存取、透明溝通、便利預約、個人化提醒和自助服務支援。醫療服務提供者正在透過升級其數位化入口，並將互動工作流程直接整合到電子健康記錄、客服中心、護理管理系統和虛擬醫療平台中來應對這一需求。

人工智慧對參與度的累積影響

人工智慧 (AI) 透過實現患者細分、預測性推廣、互動式支持、自動分診和更個人化的教育，正在加速病人參與的變革。 AI 助理可以幫助患者了解自身權益、做好就診準備、理解護理指導、管理後續事項，並接收根據其臨床風險和行為習慣量身定做的提醒。這些功能在高流量醫療中心、人群健康計畫、慢性病管理和出院後照護協調方面尤其重要。

關鍵區域洞察：全球病人參與的普及情況

北美仍然是病人參與之一，這得益於電子健康記錄的廣泛應用、以價值為導向的醫療保健、保險公司和醫療服務提供商的數位化舉措，以及對患者門戶、遠端醫療、遠距遠端患者監護和數位化入口平台的強勁需求。美國受益於美國國家衛生資訊與技術協調辦公室 (ONC) 的互通性規則、美國醫療保險和醫療補助服務中心 (CMS) 的遠端醫療報銷方案，以及領先的醫療服務提供者數位轉型計畫。同時，加拿大則強調互聯醫療、省級數位健康策略、虛擬存取以及為地理位置分散的人群提供公平的醫療服務。

策略市場定位的關鍵群體洞察

在東南亞國協，病人參與正透過行動優先的醫療服務模式、國家級數位健康計畫和醫院現代化來推動，新加坡、馬來西亞、泰國、印尼、越南和菲律賓的成熟度各不相同。該地區的部署模式與智慧型手機普及率、不斷成長的私人醫療投資、跨境醫療旅行以及島嶼、農村和醫療服務不足地區對數位醫療服務日益成長的需求密切相關。

關鍵國家對病人參與解決方案的洞察

遠端患者監護、遠端醫療入口和基於價值的醫療保健等技術的積極實施，美國已成為患者互動解決方案的領先市場。加拿大則專注於互通性、虛擬醫療、病患就醫便利性和跨省醫療協調。同時，墨西哥和巴西正透過私營部門的採用、公共系統的現代化、遠端醫療監管以及行動端驅動的醫療互動來拓展數位醫療。

為醫療產業領導者提供的實用建議

產業領導者在增加新的互動管道之前，應優先考慮互通性、可衡量的結果和工作流程整合。能夠與電子病歷 (EHR)、客戶關係管理 (CRM) 平台、客服中心、收入週期系統、藥房系統、護理管理工具和遠端監測設備整合的解決方案，可以減少碎片化，並提供更一致的患者體驗。領導者應衡量採用率、留存率、無故缺勤率降低、用藥依從性、就醫便利性改善、再入院率降低、護理缺口彌補以及患者報告的結果，以證明其運營和臨床價值。

用於分析病人參與市場的調查方法

本執行摘要是基於對檢驗的資訊來源的系統性審查，這些資源包括政策框架、監管指南、數位健康策略、保險公司和醫療服務提供者轉型計劃以及廣泛認可的衛生技術標準。主要參考文獻包括世界衛生組織 (WHO)、經濟合作暨發展組織(OECD)、世界銀行、美國國家衛生資訊科技協調辦公室 (ONC)、美國醫療保險和醫療服務中心 (CMS)、美國食品藥物管理局(FDA)、歐盟委員會、各國衛生署以及已建立的互通性框架，例如 HL7 FHIR。

結論：病人參與作為一項策略性醫療保健挑戰

病人參與解決方案正成為互聯互通、以價值主導的醫療保健的基礎。隨著醫療保健系統從被動式護理轉向主動式、持續性護理，整合溝通、訪問、教育、監測和分析的平台將在改善患者體驗、臨床結果、護理協調和營運效率方面發揮關鍵作用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章病人參與解決方案市場：按組件分類

  • 服務
    • 諮詢
    • 實施與整合
    • 培訓和支持
  • 軟體

第8章：病人參與解決方案市場：按交付管道分類

  • 網路為基礎的平台
  • 基於行動端的平台

第9章：病人參與解決方案市場：按治療領域分類

  • 心血管疾病
  • 糖尿病
  • 腫瘤學
  • 呼吸系統疾病
  • 神經病學
  • 整形外科

第10章：病人參與解決方案市場：依定價模式

  • 基於訂閱
  • 免費增值
  • 付費使用制

第11章病人參與解決方案市場：按部署模式分類

  • 基於雲端的
    • 私有雲端
    • 公共雲端
  • 現場

第12章病人參與解決方案市場：按應用領域分類

  • 預訂管理和提醒
  • 患者教育與意識
  • 遠端患者監護
  • 藥物依從性
  • 健康與生活方式管理
  • 慢性病管理

第13章：病人參與解決方案市場：按最終用戶分類

  • 醫院和診所
  • 門診部
  • 家庭醫療保健服務提供者
  • 製藥公司

第14章：病人參與解決方案市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章：病人參與解決方案市場：按群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：病人參與解決方案市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • AdvancedMD, Inc.
  • athenahealth, Inc.
  • Cerner Corporation
  • CureMD Healthcare
  • Epic Systems Corporation
  • Force Therapeutics LLC
  • GetWellNetwork, Inc.
  • Health Catalyst, Inc.
  • IQVIA Inc.
  • Kareo, Inc.
  • Klara Technologies, Inc.
  • Koninklijke Philips NV
  • Lincor Solutions Limited
  • McKesson Corporation
  • Medecision, Inc.
  • MEDHOST, Inc.
  • Meditech Information Technology, Inc.
  • NextGen Healthcare, Inc.
  • NXGN Management, LLC
  • Oneview Healthcare PLC
  • Orion Health Limited
  • ResMed Inc.
  • SpinSci Technologies, LLC
  • Tebra Technologies, Inc.
  • Veradigm LLC
  • WelVU, Inc.
  • Wolters Kluwer NV
Product Code: MRR-030EE485159B

The Patient Engagement Solution Market is projected to grow by USD 80.02 billion at a CAGR of 16.79% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 26.99 billion
Estimated Year [2026] USD 31.29 billion
Forecast Year [2032] USD 80.02 billion
CAGR (%) 16.79%

Patient engagement solutions have become a core layer of modern healthcare delivery, connecting patients, clinicians, payers, and care teams through digital front doors, patient portals, secure messaging, remote patient monitoring, appointment management, medication adherence tools, and personalized education. The category is gaining strategic importance as health systems face sustained pressure to improve access, outcomes, satisfaction, and care continuity while managing workforce constraints, rising chronic disease burden, and growing demand for hybrid care.

Verified policy and healthcare signals reinforce this shift. The World Health Organization's Global Strategy on Digital Health, the U.S. ONC interoperability agenda, CMS value-based care programs, and Europe's European Health Data Space initiatives all point toward more connected, patient-centered digital health ecosystems. For healthcare leaders, patient engagement technology is no longer a peripheral experience layer; it is an operational capability for improving quality, reducing avoidable utilization, supporting shared decision-making, and enabling data-informed care journeys.

Transformative Shifts in the Patient Engagement Landscape

The patient engagement solution landscape is being reshaped by consumer expectations, interoperability mandates, hybrid care models, and outcome-linked reimbursement. Patients increasingly expect healthcare experiences that resemble other digital services: mobile access, transparent communication, simple scheduling, personalized reminders, and self-service support. Providers are responding by modernizing the digital front door and integrating engagement workflows directly into electronic health records, contact centers, care management systems, and virtual care platforms.

A major structural shift is the move from episodic interaction to continuous engagement. Remote patient monitoring, chronic care management, virtual visits, automated outreach, and digital therapeutics are extending care beyond the clinic. At the same time, regulatory emphasis on data access, privacy, consent management, and information blocking rules is compelling vendors to build patient engagement solutions that are secure, standards-based, accessible, and interoperable across care settings.

Cumulative Impact of Artificial Intelligence on Engagement

Artificial intelligence is accelerating the evolution of patient engagement by enabling segmentation, predictive outreach, conversational support, automated triage, and more personalized education. AI-enabled assistants can help patients navigate benefits, prepare for visits, understand care instructions, manage follow-up tasks, and receive reminders aligned with clinical risk and behavioral context. These capabilities are especially valuable in high-volume access centers, population health programs, chronic disease management, and post-discharge care coordination.

The cumulative impact of AI depends on governance. Healthcare organizations are prioritizing explainability, clinical validation, bias monitoring, cybersecurity, privacy protection, and compliance with frameworks such as the NIST AI Risk Management Framework, HIPAA, GDPR, and emerging AI regulations. The strongest use cases combine automation with human oversight, ensuring AI improves patient experience, operational efficiency, and care personalization without weakening safety, trust, or equity.

Key Regional Insights Across Global Patient Engagement Adoption

North America remains one of the most mature regions for patient engagement solutions, supported by widespread electronic health record adoption, value-based care, payer-provider digital initiatives, and strong demand for patient portals, telehealth, remote patient monitoring, and digital front door platforms. The United States benefits from ONC interoperability rules, CMS reimbursement pathways for remote care, and advanced provider digital transformation programs, while Canada emphasizes connected care, provincial digital health strategies, virtual access, and equity for geographically dispersed populations.

Europe is advancing through privacy-first digital health modernization, with GDPR shaping consent, data protection, and vendor architecture. The European Union's European Health Data Space is designed to strengthen secure health data exchange and cross-border use, while the United Kingdom, Germany, France, Italy, and Spain continue investing in digital access, e-prescribing, electronic health records, and patient-facing services. Asia-Pacific is also accelerating adoption as China, India, Japan, South Korea, Australia, and ASEAN markets expand telehealth, mobile health, hospital digitalization, and AI-enabled care coordination to address aging populations, urban-rural access gaps, and chronic disease prevalence.

Latin America, the Middle East, and Africa show strong long-term potential as health systems invest in digital inclusion, mobile-first care, and public-private healthcare modernization. Brazil and Mexico remain important Latin American anchors for telehealth, private hospital digitalization, and public system modernization. The Middle East, led by GCC digital health transformation programs, is accelerating smart hospital development, connected care, and premium patient experience initiatives. Across Africa, mobile connectivity, digital public health programs, and donor-supported health infrastructure are improving patient communication, maternal health, disease surveillance, and access where traditional healthcare infrastructure remains uneven.

Key Group Insights for Strategic Market Positioning

ASEAN markets are advancing patient engagement through mobile-first healthcare delivery, national digital health programs, and hospital modernization, with Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines showing different levels of maturity. The group's adoption pattern is tied to smartphone penetration, rising private healthcare investment, cross-border medical travel, and the need to expand digital access across island, rural, and underserved communities.

The GCC is a dynamic digital health environment driven by national transformation programs, smart city investments, cloud adoption, and demand for premium patient experience in Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Bahrain, and Oman. In the European Union, patient engagement is shaped by GDPR, cross-border interoperability, digital identity, e-prescription, patient access rights, and the European Health Data Space, making compliance, consent management, localization, and standards alignment essential for vendors.

BRICS countries represent scale-driven opportunity because Brazil, Russia, India, China, and South Africa combine large patient populations with rising digital health investment, public health modernization, and increasing demand for affordable connected care. G7 markets lead in advanced adoption, reimbursement innovation, research intensity, clinical governance, and AI policy development, while NATO countries increasingly view healthcare cybersecurity, data resilience, and digital infrastructure continuity as strategic priorities for connected patient engagement platforms.

Key Country Insights in Patient Engagement Solutions

The United States is a leading market for patient engagement solutions because of mature EHR penetration, payer-provider innovation, CMS programs, and strong adoption of portals, telehealth, remote patient monitoring, digital front doors, and value-based care enablement. Canada is focused on interoperability, virtual care, patient access, and care coordination across provinces, while Mexico and Brazil are expanding digital health through private sector adoption, public system modernization, telemedicine regulation, and mobile-enabled care engagement.

In Europe, the United Kingdom continues to scale digital access through NHS programs and app-based services, Germany is supported by digital health reimbursement pathways and eHealth infrastructure, and France is advancing national digital health identity, secure health messaging, and trusted health data exchange. Italy and Spain are modernizing regional health systems with digital access, e-prescription, and patient communication tools, while Russia's patient engagement trajectory reflects domestic digital health development, localization requirements, and public sector digitalization.

China is scaling internet hospitals, online consultations, AI-enabled health services, and hospital digitalization at significant speed, while India's Ayushman Bharat Digital Mission is creating foundations for health IDs, digital records, registries, and connected care pathways. Japan prioritizes engagement for aging populations, chronic disease management, and care continuity, Australia emphasizes connected care, remote access, My Health Record integration, and rural health support, and South Korea combines advanced broadband infrastructure, hospital innovation, digital therapeutics momentum, and strong consumer technology adoption to support patient-centered engagement models.

Actionable Recommendations for Healthcare Industry Leaders

Industry leaders should prioritize interoperability, measurable outcomes, and workflow integration before adding new engagement channels. Solutions that connect with EHRs, CRM platforms, contact centers, revenue cycle systems, pharmacy systems, care management tools, and remote monitoring devices can reduce fragmentation and deliver more consistent patient experiences. Leaders should measure adoption, retention, no-show reduction, medication adherence, access improvement, readmission reduction, care gap closure, and patient-reported outcomes to demonstrate operational and clinical value.

Organizations should also embed privacy, cybersecurity, accessibility, and health equity into product strategy. Multilingual content, inclusive design, caregiver access, low-bandwidth options, mobile optimization, and digital literacy support are essential for reaching underserved populations. AI should be deployed through governed, clinically reviewed workflows that preserve trust, support transparency, reduce administrative burden, and avoid creating new operational, regulatory, or equity risks.

Research Methodology for Patient Engagement Market Analysis

This executive summary is based on a structured review of verified public sources, including policy frameworks, regulatory guidance, digital health strategies, payer and provider transformation programs, and recognized healthcare technology standards. Key reference points include the World Health Organization, OECD, World Bank, ONC, CMS, FDA, European Commission, national health ministries, and established interoperability frameworks such as HL7 FHIR.

The analysis combines secondary research, regional policy assessment, technology trend mapping, and demand-side evaluation across providers, payers, life sciences organizations, and public health systems. Insights were validated against observable healthcare priorities, including care access, chronic disease management, patient experience, virtual care adoption, value-based care, cybersecurity, interoperability, data privacy, accessibility, and AI governance.

Conclusion: Patient Engagement as a Strategic Healthcare Imperative

Patient engagement solutions are becoming foundational to connected, value-driven healthcare. As health systems shift from reactive encounters to proactive, continuous care, platforms that unify communication, access, education, monitoring, and analytics will play a critical role in improving patient experience, clinical outcomes, care coordination, and operational efficiency.

The next phase of competition will favor vendors and healthcare organizations that can combine trusted data exchange, AI-enabled personalization, regulatory compliance, cybersecurity, accessibility, and measurable impact. Leaders that invest now in interoperable, secure, and equitable engagement infrastructure will be better positioned to meet patient expectations and deliver sustainable healthcare transformation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Patient Engagement Solution Market, by Component

  • 7.1. Services
    • 7.1.1. Consulting
    • 7.1.2. Implementation & Integration
    • 7.1.3. Training & Support
  • 7.2. Software

8. Patient Engagement Solution Market, by Delivery Channel

  • 8.1. Web-Based Platforms
  • 8.2. Mobile-Based Platforms

9. Patient Engagement Solution Market, by Therapy Area

  • 9.1. Cardiovascular Diseases
  • 9.2. Diabetes
  • 9.3. Oncology
  • 9.4. Respiratory Diseases
  • 9.5. Neurology
  • 9.6. Orthopedics

10. Patient Engagement Solution Market, by Pricing Model

  • 10.1. Subscription-Based
  • 10.2. Freemium
  • 10.3. Pay-Per-Use

11. Patient Engagement Solution Market, by Deployment Mode

  • 11.1. Cloud-Based
    • 11.1.1. Private Cloud
    • 11.1.2. Public Cloud
  • 11.2. On Premise

12. Patient Engagement Solution Market, by Application

  • 12.1. Appointment Scheduling & Reminders
  • 12.2. Patient Education & Awareness
  • 12.3. Remote Patient Monitoring
  • 12.4. Medication Adherence
  • 12.5. Wellness & Lifestyle Management
  • 12.6. Chronic Disease Management

13. Patient Engagement Solution Market, by End User

  • 13.1. Hospitals & Clinics
  • 13.2. Ambulatory Care Centers
  • 13.3. Home Healthcare Providers
  • 13.4. Pharmaceutical Companies

14. Patient Engagement Solution Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Patient Engagement Solution Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Patient Engagement Solution Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. AdvancedMD, Inc.
  • 18.2. athenahealth, Inc.
  • 18.3. Cerner Corporation
  • 18.4. CureMD Healthcare
  • 18.5. Epic Systems Corporation
  • 18.6. Force Therapeutics LLC
  • 18.7. GetWellNetwork, Inc.
  • 18.8. Health Catalyst, Inc.
  • 18.9. IQVIA Inc.
  • 18.10. Kareo, Inc.
  • 18.11. Klara Technologies, Inc.
  • 18.12. Koninklijke Philips N.V.
  • 18.13. Lincor Solutions Limited
  • 18.14. McKesson Corporation
  • 18.15. Medecision, Inc.
  • 18.16. MEDHOST, Inc.
  • 18.17. Meditech Information Technology, Inc.
  • 18.18. NextGen Healthcare, Inc.
  • 18.19. NXGN Management, LLC
  • 18.20. Oneview Healthcare PLC
  • 18.21. Orion Health Limited
  • 18.22. ResMed Inc.
  • 18.23. SpinSci Technologies, LLC
  • 18.24. Tebra Technologies, Inc.
  • 18.25. Veradigm LLC
  • 18.26. WelVU, Inc.
  • 18.27. Wolters Kluwer N.V.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONSULTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONSULTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONSULTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IMPLEMENTATION & INTEGRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL IMPLEMENTATION & INTEGRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL IMPLEMENTATION & INTEGRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL TRAINING & SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TRAINING & SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TRAINING & SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL WEB-BASED PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL WEB-BASED PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL WEB-BASED PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MOBILE-BASED PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MOBILE-BASED PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MOBILE-BASED PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIABETES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DIABETES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIABETES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ORTHOPEDICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ORTHOPEDICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ORTHOPEDICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SUBSCRIPTION-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SUBSCRIPTION-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SUBSCRIPTION-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FREEMIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FREEMIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FREEMIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PAY-PER-USE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PAY-PER-USE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PAY-PER-USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CLOUD-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CLOUD-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CLOUD-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PRIVATE CLOUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PRIVATE CLOUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PRIVATE CLOUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PUBLIC CLOUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PUBLIC CLOUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PUBLIC CLOUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ON PREMISE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ON PREMISE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ON PREMISE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL APPOINTMENT SCHEDULING & REMINDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL APPOINTMENT SCHEDULING & REMINDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL APPOINTMENT SCHEDULING & REMINDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PATIENT EDUCATION & AWARENESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PATIENT EDUCATION & AWARENESS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PATIENT EDUCATION & AWARENESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL REMOTE PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL REMOTE PATIENT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL REMOTE PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICATION ADHERENCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICATION ADHERENCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICATION ADHERENCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL WELLNESS & LIFESTYLE MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL WELLNESS & LIFESTYLE MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL WELLNESS & LIFESTYLE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HOME HEALTHCARE PROVIDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HOME HEALTHCARE PROVIDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HOME HEALTHCARE PROVIDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 172. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 173. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 174. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 176. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 177. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 178. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 179. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 203. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 204. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 206. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 207. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 208. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 209. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 213. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 214. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 216. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 217. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 218. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 219. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 234. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 235. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 237. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 238. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 239. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 240. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 244. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 245. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 247. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 248. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 249. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 250. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 254. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 255. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 256. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 257. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 258. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 259. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 260. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 273. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 274. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 275. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 277. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 278. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 279. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 280. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 281. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 283. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 284. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 285. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 286. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 287. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 288. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 289. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 290. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 294. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 295. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 296. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 297. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 298. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 299. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 300. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 301. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 303. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 304. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 305. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 306. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 307. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 308. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 309. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 310. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 311. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 312. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 314. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 315. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 316. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 317. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 318. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 319. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 320. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 321. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 329. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 330. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 331. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 332. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 333. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 334. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 335. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 336. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 337. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 338. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 339. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
  • TABLE 340. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 341. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 342. JAPAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 343. JAPAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 344. JAPAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 345. JAPAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY CHANNEL, 2018-2032 (USD MILLIO